Coronary Artery Bypass Graft clinical trials

Explore recruiting coronary artery bypass graft clinical trials.

Recruiting coronary artery bypass graft studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coronary Artery Bypass Graft trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG - PACeS

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I Randomised Double-Blind Placebo Controlled Safety Study of Intramyocardial Injection of CLXR-001 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Hungary

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A 26-Week (with 26 Week Extension) Randomized, Multi-Center, Double-Blind Phase 2 Study to Evaluate the Efficacy and Safety of XC001 Gene Therapy as an Adjunct to Coronary Artery Bypass Graft Surgery for Patients with Symptomatic Coronary Artery Disease with Left Ventricular Dysfunction at Risk for Incomplete Revascularization

Netherlands, Germany, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

LEONARD.LEvOsimendaN vs. Placebo Before Tricuspid VAlve Surgery in Patients with Right Ventricular Dysfunction (LEONARD)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Multi-center, Randomized, Dose-Ranging, Placebo-Controlled, Double-blind Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated - Acute Kidney Injury.

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Coronary Artery Bypass Graft trials by city

Coronary Artery Bypass Graft in Toronto Coronary Artery Bypass Graft in Vancouver Coronary Artery Bypass Graft in Montreal Coronary Artery Bypass Graft in Calgary Coronary Artery Bypass Graft in Edmonton Coronary Artery Bypass Graft in Ottawa Coronary Artery Bypass Graft in Winnipeg Coronary Artery Bypass Graft in Quebec City Coronary Artery Bypass Graft in Hamilton Coronary Artery Bypass Graft in Kitchener Coronary Artery Bypass Graft in London Coronary Artery Bypass Graft in Halifax Coronary Artery Bypass Graft in New York Coronary Artery Bypass Graft in Los Angeles Coronary Artery Bypass Graft in Chicago Coronary Artery Bypass Graft in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease